Ticker Details
Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
IPO Date:	March 11, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.13B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.11%
Avg Daily Range (30 D):	$0.16 | 2.72%
Avg Daily Range (90 D):	$0.16 | 2.99%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	1.32M
Avg Daily Volume (90 D):	1.97M

Trade Size
Avg Trade Size (Sh.):	170
Avg Trade Size (Sh.) (30 D):	96
Avg Trade Size (Sh.) (90 D):	128

Institutional Trades
Total Institutional Trades:	544
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$.93M
Avg Institutional Trade (90 D):	$1.39M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.81M
Avg Closing Trade (30 D):	$.89M
Avg Closing Trade (90 D):	$1.51M
Avg Closing Volume:	406.76K

News

Feb 4, 2026 @ 9:05 PM Savara Announces Participation in Upcoming Investo... Source: Business Wire

Jan 24, 2026 @ 4:38 PM SAVARA INVESTIGATION ALERT: Bragar Eagel & Squire,... Source: Bragar Eagel & Squire, P.C.

Dec 17, 2025 @ 1:05 PM Savara Announces Participation in the 44th Annual ... Source: Business Wire

Nov 20, 2025 @ 9:05 PM Savara Announces Participation in Upcoming Investo... Source: Business Wire

Nov 7, 2025 @ 7:22 AM SVRA Investors Have Opportunity to Lead Savara Inc... Source: Prnewswire

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.14		$-.12
Diluted EPS	$-.14		$-.12
Revenue	$M		$M
Gross Profit
Net Income / Loss	$-29.56M	$-30.4M	$-26.64M
Operating Income / Loss	$-30.26M		$-28.44M
Cost of Revenue
Net Cash Flow			$4.46M
PE Ratio

Splits
Apr 28, 2017	1:70
Apr 26, 2010	1:25
Jul 26, 2000	1:2